Aviva PLC Rhythm Pharmaceuticals, Inc. Transaction History

Aviva PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$20.25 - $39.49 $976,414 - $1.9 Million	-48,218 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$21.17 - $32.61 $827,514 - $1.27 Million	-39,089 Reduced 44.77%	48,218 $1.43 Million
Q3 2020 Nov 12, 2020	SELL	$18.13 - $30.61 $456,984 - $771,555	-25,206 Reduced 22.4%	87,307 $1.89 Million
Q2 2020 Aug 13, 2020	SELL	$14.41 - $25.35 $286,312 - $503,679	-19,869 Reduced 15.01%	112,513 $2.51 Million
Q1 2020 May 14, 2020	BUY	$13.16 - $22.9 $1.74 Million - $3.03 Million	132,382 New	132,382 $2.02 Million

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.46B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.